Concepedia

Heather Lawlor

HL

Statistics

Publications

10

Citations

754

H-Index

10

Active since

2004

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Icahn School of Medicine at Mount Sinai

Heather Lawlor is an author at National Institutes of Health specializing in infectious diseases, immunology, and virology.

Publications per year

2004–2023

10

Publications

10

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 163 citations · Full text

, , +16

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

, , +14

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Alicia T. Widge, Amelia R. Hofstetter, Katherine V. Houser et al. · Science Translational Medicine · 2023 · 96 citations · Full text

, , +17

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

Roderick S. Tang, Kutubuddin Mahmood, Mia MacPhail et al. · Vaccine · 2004 · 94 citations · Full text

, , +17

Parainfluenza Virus Type 3 Expressing the Native or Soluble Fusion (F) Protein of Respiratory Syncytial Virus (RSV) Confers Protection from RSV Infection in African Green Monkeys

Roderick S. Tang, Mia MacPhail, Jeanne H. Schickli et al. · Journal of Virology · 2004 · 89 citations

, , +17

1–5 of 10